Silexion Therapeutics Corp. will execute a 1-for-24 reverse stock split effective November 11, 2026, alongside a par value change to $3.24 and a new CUSIP identifier of G1281K163.
Silexion will effect a one-for-twenty-four (1-24) reverse split and a par value change from $0.135 to $3.24 effective Wednesday, November 11, 2026, with the CUSIP changing to G1281K163. A reverse split reduces share count and raises the per-share price proportionally, so it is mechanically value-neutral and typically does not move the price beyond technical trading effects. The split itself signals no change in fundamentals, though reverse splits are often pursued to maintain listing standards.
Silexion Therapeutics Corp. (SLXN) announced a 1-for-24 reverse stock split scheduled to take effect on Wednesday, November 11, 2026. The corporate action includes a par value adjustment from $0.135 to $3.24 and a change in the company's CUSIP number to G1281K163.
Starting November 11, 2026, every 24 shares you hold will be converted into 1 share, and the share price will be adjusted proportionally, so the total value of your position stays the same.
No. The 1-for-24 split only reduces the share count and raises the per-share price; it does not change the company's market value or fundamentals.